174
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Development of prednisolone-containing eye drop formulations by cyclodextrin complexation and antimicrobial, mucoadhesive biopolymer

, , , , , , , & show all
Pages 2529-2537 | Published online: 15 Aug 2018

References

  • KaurIPKanwarMOcular preparations: the formulation approachDrug Dev Ind Pharm200228547349312098838
  • LoftssonTStefánssonECyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eyeActa Ophthalmol Scand200280214415011952479
  • KunoNFujiiSRecent advances in ocular drug delivery systemsPolymers201131193221
  • LoftssonTStefánssonEEffect of cyclodextrins on topical drug delivery to the eyeDrug Dev Ind Pharm1997235473481
  • ChallaRAhujaAAliJKharRKCyclodextrins in drug delivery: an updated reviewAAPS PharmSciTech200562E329E35716353992
  • LoftssonTDuchêneDCyclodextrins and their pharmaceutical applicationsInt J Pharm20073291–211117137734
  • SzenteLSzejtliJHighly soluble cyclodextrin derivatives: chemistry, properties, and trends in developmentAdv Drug Deliv Rev1999361172810837706
  • LoftssonTFriðriksdóttirHThórisdóttirS2-hydroxypropyl-β-cyclodextrin in topical carbonic anhydrase inhibitor formulationsEur J Pharm Sci199414175180
  • Saarinen-SavolainenPJärvinenTAraki-SasakiKWatanabeHUrttiAEvaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell linePharm Res1998158127512809706061
  • KissTFenyvesiFBácskayIEvaluation of the cytotoxicity of beta-cyclodextrin derivatives: evidence for the role of cholesterol extractionEur J Pharm Sci201040437638020434542
  • JärvinenKJärvinenTUrttiAOcular absorption following topical deliveryAdv Drug Deliv Rev1995161319
  • AndrewsGPLavertyTPJonesDSMucoadhesive polymeric platforms for controlled drug deliveryEur J Pharm Biopharm200971350551818984051
  • MansuriSKesharwaniPJainKTekadeRKJainNKMucoadhesion: a promising approach in drug delivery systemReact Funct Polym2016100151172
  • GuterMBreunigMHyaluronan as a promising excipient for ocular drug deliveryEur J Pharm Biopharm2017113344927914235
  • LaiJYTuIHAdhesion, phenotypic expression, and biosynthetic capacity of corneal keratocytes on surfaces coated with hyaluronic acid of different molecular weightsActa Biomater2012831068107922134163
  • HorvátGGyarmatiBBerkóSzThiolated poly(aspartic acid) as potential in situ gelling, ocular mucoadhesive drug delivery systemEur J Pharm Sci20156711125445832
  • ChapmanJMCheeksLGreenKInteractions of benzalkonium chloride with soft and hard contact lensesArch Ophthalmol199010822442462302109
  • SwierczRHałatekTMajcherekWGrzelińiskaZWasowiczWToxic effect of benzalkonium chloride on animals and humansMed Pr200758213914217926503
  • YeJWuHZhangHRole of benzalkonium chloride in DNA strand breaks in human corneal epithelial cellsGraefes Arch Clin Exp Ophthalmol2011249111681168721842132
  • SakagamiYYokoyamaHNishimuraHOseYTashimaTMechanism of resistance to benzalkonium chloride by Pseudomonas aeruginosaAppl Environ Microbiol1989558203620402506813
  • PasquetJChevalierYCouvalEBouvierDBolzingerMAZinc oxide as a new antimicrobial preservative of topical products: interactions with common formulation ingredientsInt J Pharm20154791889525527211
  • IllésJJávorASzíjártóEZinc-hyaluronate: an original organotherapeutic compound of Gedeon Richter LtdActa Pharm Hung2002721152412426784
  • SandriGBonferoniMCRossiSThermosensitive eyedrops containing platelet lysate for the treatment of corneal ulcersInt J Pharm20124261–21622248667
  • HiguchiTConnorsKAPhase-solubility techniquesReilyCNAdvances in Analytical Chemistry and Instrumentation4New YorkInterscience1965117212
  • ReptaAJAlteration of apparent solubility through complexationYalkowskiSHTechniques of Solubilization of DrugsNew YorkMarcel Dekker1985135157
  • HorvátGBudai-SzűcsMBerkóSzCsányiEComparative study of nanosized cross-linked sodium-, linear sodium- and zinc-hyaluronate as potential ocular mucoadhesive drug delivery systemsInt J Pharm2015494132132826319587
  • DataphysicsOperating Manual OCA (OCA 5, OCA 10, OCA 15, OCA 15 plus, OCA 20, OCA 30, OCAH 200 and OCAH 230)200271
  • European Directorate for Quality of Medicines. Efficacy of Antimicrobial PreservationEuropean Pharmacopoeia9th edStrasbourgEuropean Directorate for the Quality of Medicines200651295130
  • CappelloBde RosaGGianniniLCyclodextrin-containing poly(ethyleneoxide) tablets for the delivery of poorly soluble drugs: potential as buccal delivery systemInt J Pharm20063191–2637016650700
  • WoertzCPreisMBreitkreutzJKleinebuddePAssessment of test methods evaluating mucoadhesive polymers and dosage forms: an overviewEur J Pharm Biopharm2013853 Pt B84385323851076
  • SzűcsMSandriGBonferoniMCMucoadhesive behaviour of emulsions containing polymeric emulsifierEur J Pharm Sci2008344–522623518513929
  • OechsnerMKeipertSPolyacrylic acid/polyvinylpyrrolidone bipoly-meric systems. I. Rheological and mucoadhesive properties of formulations potentially useful for the treatment of dry-eye-syndromeEur J Pharm Biopharm199947211311810234534
  • SalzilloRSchiraldiCCorsutoLOptimization of hyaluronan-based eye drop formulationsCarbohydr Polym201615327528327561497
  • TiffanyJMWinterNBlissGTear film stability and tear surface tensionCurr Eye Res1989855075152736956
  • HanKWoghirenOEPrieferRSurface tension examination of various liquid oral, nasal, and ophthalmic dosage formsChem Cent J2016103127162532
  • Hotujac GrgurevićMJuretićMHafnerALovrićJPepićITear fluid-eye drops compatibility assessment using surface tensionDrug Dev Ind Pharm201743227528227645109
  • DoschiUXuJEffect of viscosity, surface tension and mucoadhesion on ocular residence time of lubricant eye dropsInvest Ophthalmol Vis Sci2009504641
  • LoftssonTStefánsdóttirÓFriôriksdóttirHGuômundssonÖInteractions between preservatives and 2-hydroxypropyl-β-cyclodextrinDrug Dev Ind Pharm1992181314771484